РпоÑледние Ð³Ð¾Ð´Ñ ÑазвиÑие биоÑÐµÑ Ð½Ð¾Ð»Ð¾Ð³Ð¸Ð¹, ÑпоÑобÑÑвÑÑÑÐ¸Ñ ÑлÑÑÑÐµÐ½Ð¸Ñ Ð·Ð´Ð¾ÑовÑÑ Ñеловека, акÑивно пÑодвигаеÑÑÑ Ð¿Ð¾ вÑÐµÐ¼Ñ Ð¼Ð¸ÑÑ. СÑаÑÑап AETech LLC занимаеÑÑÑ ÑазÑабоÑкой новÑÑ ÑÐµÑ Ð½Ð¾Ð»Ð¾Ð³Ð¸Ð¹ в облаÑÑи биоÑÐµÑ Ð½Ð¾Ð»Ð¾Ð³Ð¸Ð¹. ÐÑодÑкÑом компании ÑвлÑеÑÑÑ Ð¿ÑоÑилакÑиÑеÑкое ÑÑедÑÑво ÑазвиÑÐ¸Ñ Ð·Ð°Ð±Ð¾Ð»ÐµÐ²Ð°Ð½Ð¸Ð¹ паÑодонÑа, паÑодонÑа и ÑлизиÑÑой оболоÑки полоÑÑи ÑÑа. ÐÐ¾Ð¼Ð¿Ð°Ð½Ð¸Ñ Ð¿Ð»Ð°Ð½Ð¸ÑÑÐµÑ Ð¿ÑоизводÑÑво ÑолÑко за пÑеделами ÑÑнка РФ. Таким обÑазом, ÑелÑÑ Ð´Ð°Ð½Ð½Ð¾Ð³Ð¾ иÑÑÐ»ÐµÐ´Ð¾Ð²Ð°Ð½Ð¸Ñ ÑвлÑеÑÑÑ ÑазÑабоÑка комплекÑа ÑекомендаÑий по вÑÐ²Ð¾Ð´Ñ Ð±Ð¸Ð¾ÑÐµÑ Ð½Ð¾Ð»Ð¾Ð³Ð¸ÑеÑкого ÑÑаÑÑапа AETech LLC на ÑÑнок ÑÑÑан ÐвÑоÑоÑза Ñ ÑÑеÑом оÑÑÑÑÑÑÐ²Ð¸Ñ Ð¾Ð¿ÑÑа ÑабоÑÑ AETech LLC на ÑÑом ÑÑнке. Ð Ñнок биоÑÐµÑ Ð½Ð¾Ð»Ð¾Ð³Ð¸Ð¹ акÑивно ÑазвиваеÑÑÑ Ð² ÐвÑопейÑком ÑоÑзе, однако подÑобнÑе иÑÑÐ»ÐµÐ´Ð¾Ð²Ð°Ð½Ð¸Ñ Ð² облаÑÑи инÑеÑнаÑионализаÑии биоÑÐµÑ Ð½Ð¾Ð»Ð¾Ð³Ð¸ÑеÑÐºÐ¸Ñ ÑÑаÑÑапов в Ñвободном доÑÑÑпе оÑÑÑÑÑÑвÑÑÑ. ÐоÑÑÐ¾Ð¼Ñ Ð±Ñло ÑеÑено ÑазÑабоÑаÑÑ Ð¾Ð¿Ð¸ÑаÑелÑное иÑÑледование, ÑобиÑаÑÑее даннÑе из ÑазлиÑнÑÑ Ð¸ÑÑоÑников на полиÑиÑеÑÐºÐ¸Ñ , ÑкономиÑеÑÐºÐ¸Ñ Ð¸ дÑÑÐ³Ð¸Ñ ÑÑовнÑÑ , ÑÑÐ¾Ð±Ñ Ð¸Ð¼ÐµÑÑ Ð¿ÑедÑÑавление о ÑÑнке ÐвÑоÑоÑза Ñ ÑоÑки зÑÐµÐ½Ð¸Ñ ÐµÐ³Ð¾ пеÑÑпекÑивноÑÑи Ð´Ð»Ñ Ð¸Ð½ÑеÑнаÑионализаÑии биоÑÐµÑ Ð½Ð¾Ð»Ð¾Ð³Ð¸ÑеÑкого ÑÑаÑÑапа AETech LLC. ÐпоÑледÑÑвии бÑли пÑÐ¸Ð¼ÐµÐ½ÐµÐ½Ñ ÑÑаÑиÑÑиÑеÑкие меÑÐ¾Ð´Ñ Ð´Ð»Ñ Ð¾Ñенки Ñого, в ÐºÐ°ÐºÐ¸Ñ ÑÑÑÐ°Ð½Ð°Ñ ÑÑаÑÑап AETech LLC Ð¼Ð¾Ð¶ÐµÑ Ð±ÑÑÑ Ð²Ð¾ÑÑÑебован, а Ñакже ÑазÑабоÑан Ð½Ð°Ð±Ð¾Ñ ÑекомендаÑий Ð´Ð»Ñ Ð¸Ð½ÑеÑнаÑионализаÑии., In recent years, the development of health-enhancing biotechnology has been promoted from various angles around the world. A start-up company AETech LLC is developing new technologies in the field of biotechnology. The company's product is a prophylactic agent for the development of periodontal, periodontal and oral mucosa diseases. The company plans to produce it only outside the Russian market. Thus, the purpose of this study is to develop a set of recommendations for the introduction of a biotech startup AETech LLC to the EU market, considering the lack of experience of AETech LLC in this market. The biotechnology market is actively developing in the European Union, but detailed studies on the internationalization of biotech start-ups are not freely available. Therefore, it was decided to develop a descriptive study collecting data from different sources on political, economic, social, and industrial levels in order to have an overview of the EU market in terms of its prospects for internationalization of a biotech start-up AETech LLC. Subsequently, statistical methods were applied to assess in which countries the AETech LLC startup could be in demand and a set of recommendations for its internationalization were developed.